高级检索
当前位置: 首页 > 详情页

Nanotechnology based therapeutic modality to boost anti-tumor immunity and collapse tumor defense

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ EI

单位: [1]Tongji Sch Pharm, Wuhan, Hubei, Peoples R China [2]Tongji Hosp, Dept Pharm, Wuhan, Hubei, Peoples R China [3]Natl Engn Res Ctr Nanomed, Wuhan, Hubei, Peoples R China [4]Huazhong Univ Sci & Technol, Hubei Engn Res Ctr Novel Drug Delivery Syst, Wuhan 430030, Peoples R China
出处:
ISSN:

关键词: Nanotechnology Immunotherapy Tumor microenvironment Dendritic cells Vaccination Adoptive T cell therapy Checkpoint therapy Immunosuppression

摘要:
Cancer is still the leading cause of death. While traditional treatments such as surgery, chemotherapy and radiotherapy play dominating roles, recent breakthroughs in cancer immunotherapy indicate that the influence of immune system on cancer development is virtually beyond our expectation. Manipulating the immune system to fight against cancer has been thriving in recent years. Further understanding of tumor anatomy provides opportunities to put a brake on immunosuppression by overcoming tumor intrinsic resistance or modulating tumor microenvironment. Nanotechnology which provides versatile engineered approaches to enhance therapeutic effects may potentially contribute to the development of future cancer treatment modality. In this review, we will focus on the application of nanotechnology both in boosting anti-tumor immunity and collapsing tumor defense.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 1 区 医学
小类 | 1 区 药学 2 区 化学综合
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 药学 2 区 化学:综合
JCR分区:
出版当年[2015]版:
Q1 PHARMACOLOGY & PHARMACY Q1 CHEMISTRY, MULTIDISCIPLINARY
最新[2023]版:
Q1 CHEMISTRY, MULTIDISCIPLINARY Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者单位: [1]Tongji Sch Pharm, Wuhan, Hubei, Peoples R China
通讯作者:
通讯机构: [1]Tongji Sch Pharm, Wuhan, Hubei, Peoples R China [3]Natl Engn Res Ctr Nanomed, Wuhan, Hubei, Peoples R China [4]Huazhong Univ Sci & Technol, Hubei Engn Res Ctr Novel Drug Delivery Syst, Wuhan 430030, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:0 总访问量:408 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)